Gerresheimer (GXI) Given a €55.00 Price Target at Hauck & Aufhaeuser

Hauck & Aufhaeuser set a €55.00 ($65.48) price target on Gerresheimer (ETR:GXI) in a research note issued to investors on Wednesday. The firm currently has a sell rating on the stock.

Several other research firms also recently weighed in on GXI. JPMorgan Chase & Co. set a €87.70 ($104.40) target price on Gerresheimer and gave the company a buy rating in a research report on Thursday, January 4th. Berenberg Bank set a €75.00 ($89.29) price objective on Gerresheimer and gave the company a buy rating in a research report on Friday, December 8th. Kepler Capital Markets set a €65.00 ($77.38) price objective on Gerresheimer and gave the company a sell rating in a research report on Friday, November 3rd. Deutsche Bank set a €64.00 ($76.19) price objective on Gerresheimer and gave the company a neutral rating in a research report on Friday, December 1st. Finally, Commerzbank set a €77.00 ($91.67) price objective on Gerresheimer and gave the company a buy rating in a research report on Monday, October 23rd. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company. Gerresheimer has a consensus rating of Hold and an average price target of €70.62 ($84.07).

Gerresheimer (GXI) opened at €71.65 ($85.30) on Wednesday. The firm has a market capitalization of $2,250.00 and a price-to-earnings ratio of 50.82. Gerresheimer has a 52-week low of €59.97 ($71.39) and a 52-week high of €78.25 ($93.15).

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Transcript Daily and is owned by of Transcript Daily. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://transcriptdaily.com/2018/01/14/gerresheimer-gxi-given-a-55-00-price-target-at-hauck-aufhaeuser.html.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply